SABCS 2024 Highlights

EP. 1: INSEMA: No Axillary Surgery vs. Axillary SLNB in Pts With Early Invasive Breast Cancer

ByRahul Gosain, MD,Rohit Gosain, MD,Laura Huppert, MD

January 9th 2025

Panelists discuss the INSEMA trial, comparing no axillary surgery versus axillary sentinel lymph node biopsy (SLNB) in patients with early invasive breast cancer, exploring the implications for treatment decisions and patient outcomes.

EP. 2: KEYONTE-522: Exploratory Biomarker Analysis in Periop Pembro vs. Placebo + Chemo

ByRahul Gosain, MD,Rohit Gosain, MD,Laura Huppert, MD

January 9th 2025

Panelists discuss the exploratory biomarker analysis from the KEYNOTE-522 trial, comparing perioperative pembrolizumab versus placebo plus chemotherapy in early-stage breast cancer, and its implications for treatment strategies.

EP. 3: OlympiA: Adj Olaparib Post (Neo) Adjuvant Chemo in Pts with Germline BRCA1/BRCA2 & High Risk HER2-negative

ByRahul Gosain, MD,Rohit Gosain, MD,Laura Huppert, MD

January 9th 2025

Panelists discuss the OlympiA trial, evaluating adjuvant olaparib post-neoadjuvant chemotherapy in patients with germline BRCA1/BRCA2 mutations and high-risk HER2-negative breast cancer, and its impact on treatment outcomes.